(State or Other Jurisdiction | (Commission | (IRS Employer | ||||||
of Incorporation) | File Number) | Identification No.) |
(Address of Principal Executive Offices) | (Zip Code) |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: | ||||||||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
WEREWOLF THERAPEUTICS, INC. | ||||||||
Date: May 28, 2021 | By: | /s/ Timothy W. Trost | ||||||
Timothy W. Trost | ||||||||
Chief Financial Officer and Treasurer |
Cover Page Document |
May 27, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | May 27, 2021 |
Entity Registrant Name | WEREWOLF THERAPEUTICS, INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-40366 |
Entity Tax Identification Number | 82-3523180 |
Entity Address, Address Line One | 1030 Massachusetts Ave |
Entity Address, Address Line Two | Ste 210 |
Entity Address, City or Town | Cambridge |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02138 |
City Area Code | (617) |
Local Phone Number | 952-0555 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, $0.0001 par value per share |
Trading Symbol | HOWL |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Entity Central Index Key | 0001785530 |
Amendment Flag | false |
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end
@?[)_>1FY_ZAON[0=]B"='9MO6 M#BNDN_)VHK@1;#1PN]*HL]K9QK5N?T@7:Y'>MLK^B+;;N)_3P>8<&59+7ZR W9F[$[7M$4=#=V="=7YW M-[2'^,FJUL?E\D86]952GTD_@HD A$"L S-!%B" 5.1H+Z(1""%XPITH[.I MH=U87ETI/LQR=-/J_ +: ^6O=Y M[Y/G'?U,;;C83 JOM7HKL=Y:K?74>:NUO6?/AQHVT@2ZI5
2!]0&.. M]*$_YS1"?;'?BCPUT-?BO)6Z_F!OV[4?96<3CCU#UB]_*UA; K@S^C99R[BNE2!!@0!-SI2@)0D D%P!2PI40F"@6]86O MM8>I0?APK\A*I:=E>D9G?QS;C=R/Y6![CHRGM3-6H.[,W@G8]HBC@;LSH3K MNQLZ+#KEBY2GI1X3_M"!BI0NYDQB!F,D]3FV1AF'A.LMP4&(*2&(Z1=#VGO9 MJ1%^:@@_*O0V$BT6G9KN]5AV&N3)D;FUL<-NT:DS:[=EIV:X\1:>.E/96GKJ M;N5>;\_U1^=2D80A(0!5' +,S;V%',5 R#A&G 4PC)AMF36!IX;F0PTQXNQ+ M:N55_TIJZ\!8!71G\DY5LY[IH&)9!1J]1M;EMY7&K??M43LUUW86DI[F0J/& M=<4C% ,!F0\PUC\(DHFY&\)<=RGUO]ZHU0-/#;73ZC)B+ N]%\K MM^2VC^]]IWD/YN8XT[V#C'28^^UESX YX-WQ1YX+[I5L B\I=_8RT:'DX7:A]89GQ'J? M,]?;J[:,[3MJ#+1KG+'"WBGW^ZK:G!A^4]56U.>YHZHML<[;J5H;NX+_55ZD MR[*@6?E)?]=SP1B+((4 Q8D^F$>^!(0J#%BBB'Y)J#"T9'Z[@XGB_BC2,RIM M(7]B8E^^W:T9!^V^KC@ W9[Z ):?!!P9X_9TF@1WM#M ]EHABWUZ+SVWQXU48#JK:57<]9M7 =YB!U'QMC""2MPNU)VXK41;#1,N]*H MT]G99F U-M-^GXOS_#:; 8%EHX^I M(?JTOE3SQGGA&:V.5;AFJ&4-=K-IY K "LY;0EL M+>6T-AA8*+[DRY(N_I->5TL)?D2@8E$$J."Z5F!]WD8P"H#2YVP(DC 6HO=5 MN=W=3+U M&7ZO<2T>K$\.KQW;8YRD@K:EUUI#V MUJ[XG\I,CR.+CYF0=_^6]W.1P)##( *^7YW!F>?9J%"!@( ,PWM\9![@[LA_ ]=.((R/=D5"3YJZ&[L^A M>7_'+_7W)ZMI?RDDC 0/ \C!+ O8\!$G( @E(@BY%-]$FC[+)IZ!U/#>*/1 MVXBT7#MI-7$_PT.M.3+"EJXX/96F+?5!3Z;9"CCZTVG:TFE[0DUKNRYXZXZ? MZ:VW+S:OI*O_*N/MB_\#4$L#!!0 ( $Q O%+\?U;K"P< #4U 5 M:&]W;"TR,#(Q,#4R-U]P &ULU9M;4]M8$L??^11>]G4//C>="Y4PQ3+) M%C7,A$J8RM2\J,ZECU%%EBA)!//MMR5@)]QF-,A;*"_8EH_5W?_^^:B[+=[\ ML%F7BZ_0M$5=O=UE>W1W 56H8U&MWN[^>O:>F-T?#G9VWOR#D-_^_?%D\6,= M+M=0=8NC!EP'<7%5=.>+SQ':+XO4U.O%Y[KY4GQUA!P,'SJJ+ZZ;8G7>+3CE M[.&[S;ZB,H$6@E@I')&4"V+ 2B(H!2J#CM&H?ZWV(2I/HY#$!D&)3!J?> =]W%_G)Y=76UM_%-N5 +M\\6G\EAM7,6KL EBU_^_GD4SB'M2-%U7:N"KV! MMMAOAX,G=7#=H/E?^K5X=D7_BMPM(_TAPC@1;&_3QMV#G<7B1HZF+N$CI$7_ M^.O'X_L>0P-7=9FZS5ZHU\M^R?*H1B!.W0KNDHV.#R?JKB_@[6Y;K"]*N#MV MWD#",]97)>DS3#.N>_/_?'R2Y1\>7330XJ%!@1,\<'NNWOI4[V#3017A)OX[ M>V4=[BTJ>_7KYNZ3I?-0#D?S"$4^6#CT;=>XT.6"AI2HY$0%)HB4UA!O,DZ\ M]094,()'_T ,#*#%"(9DM1#V5O77)9YXV0O4/QF4&E1Z9.Y&I9?Y?2?(&:[- M;1:MHBH2_,+@-\8+3[SGG+"8A%$\!0EVDMO?6KOO];?9/6S"HFXB-+BYW)ES M37B4Z?M@WZY87K@&3T3">5'&NT_WN\PV M)LAR]5A*( MM5$3SVS0+@K-13:)A:>LCD)!S!>%R4K.@H1CK..:B[H9A/^$^L-1?5EUS?51 M'2$W.BHM(A9>6ALB+ !*&H5@.#8@&6(,4A'? :):$DU-FR9$EQO 85GS(_B0LV= MBVUH.PM(#F/$%+2W#]C 5,&BMU2-AE#W618<0+PPE $BE*+IW?Q@7ED>%14-CO M!(H7ZCDG)(:"^4-SVM1?BRI S@1>\9A(A'F#<3@,QB6!%9/G.FKN5.;=]KAX M8'W<'(M^)W1,D79.B)S6;>?*WXN+H:&*(HLZ&>R^@^=$)H^71\4E2 M8]+3R\O2\KNX:ZPBX?6G!2)8Q3; <1EP]E22# MX .%Y!.(26E_:'% X,Z% M[9$*@OCD'4G!\BP8HW68-L)\TNPX$&8\M9PNYBO3\*DNBU!T1;7Z&0N &X+2!GF# MPG;XY;;_T;_YD-"/W"D%C%E4P'&/*.O^1QJ*K5#D 8"R3&LS"8;G;8^#8L:3 MRBW).B\XCMOV$IIO8Z%.1*LX$,8BQN*U(X[QC&B;J-)*.&6G=9E_Y<$X4&8\ MM=RJQ*]]08%PB1?%:\;]6=&5V Q1EK10&7$Z8C,$#'WGG!&-L>@D.0U43KN< M/+ X#H<9SRHG2?C*Z3]K7'^_XZ?KM:_+G"G* \60M?!8%CN!79$.&N,0UM/ MI/)A4N[OF1N7^!G/(U\NWDR^].\VX=Q5*QAN\I!11?0WPQ[82R+1:V*Q)R;4 M:Z[! +VX6KKG.I:43G M);&,85^4,MS'*$8EK!%:< >>TDE$_(GQ<6#,?MXX7=AY\+'!O:YJBU[_FYL$ M 1,>-!Y%8DG0461ZA7X\IC MK'PW/\%U[BDD#"(0#@$#$)G"NM<+@F6/PT,1DI]V]^V39L/QY'0Q7YF& M0VR#8M\*O2_=*F<^<:ZI)B&CZ'C \M '-D4$L! A0#% @ 3$"\4H9,_"[O"@ ^&0 !4 M ( !QAL &AO=VPM,C R,3 U,C=?;&%B+GAM;%!+ 0(4 Q0 M ( $Q O%+\?U;K"P< #4U 5 " >@F !H;W=L+3(P D,C$P-3(W7W!R92YX;6Q02P4& 0 ! $ 0 )BX end